Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.36 USD | +2.61% |
|
+5.36% | +81.54% |
Jun. 04 | LadRx Corporation and ImmunityBio, Inc. Mutually Agree to Terminate Aldoxorubicin License | CI |
May. 15 | LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LADRX CORPORATION | Other Biotechnology & Medical Research | +2.61% | +5.36% | +81.54% | +12.92% | -92.88% | 1.17M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- LADX Stock
- Charts LadRx Corporation
- Comparison Chart